Mexico Federal Congress Bans E-cigarettes and Fentanyl Misuse

Jan.13
Mexico Federal Congress Bans E-cigarettes and Fentanyl Misuse
Mexico's Congress committee bans e-cigarettes and illegal fentanyl use, amending the Political Constitution to protect public health.

On January 8th, the Mexican Federal Congress Standing Committee announced during a meeting that they will be adding a fifth item to Article 4 and a second item to Article 5 of the Political Constitution, prohibiting the use of e-cigarette products and the illegal use of fentanyl.


Previously, the Mexican Senate Plenary Session approved the above-mentioned bill with a vote of 110 in favor, 5 against, and 2 abstentions, clearly prohibiting the production, distribution, and sale of e-cigarettes, all types of e-cigarette devices, and other similar devices.


Senator Gerardo Fernández Noroña, who serves as the chairman of the permanent committee, stated during a meeting that the declaration was released after tallying majority votes from various states and the Mexico City parliament. In order to protect public health, the constitutional provisions will be revised and submitted to the federal government for action.


Previously, the Secretary General of the Standing Committee and Congresswoman Magdalena del Socorro Núñez Monreal read out the relevant letter from the Senate, confirming the receipt of 22 affirmative votes from various parliamentary bodies.


According to the revised constitution, in order to protect the public's right to health, the law will punish any activities related to e-cigarettes and similar devices, as well as the production, distribution, and sale of toxic substances, chemical precursors, illegal use of fentanyl, and other unauthorized synthetic drugs.


We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

U.S. FDA to Review Philip Morris International’s IQOS Risk Modification Renewal Application in October
U.S. FDA to Review Philip Morris International’s IQOS Risk Modification Renewal Application in October
The U.S. FDA will review Philip Morris International’s renewal application for five IQOS products' modified risk status at an October 7 TPSAC meeting, evaluating whether they still meet the required standards.
Jul.30 by 2FIRSTS.ai
U.S. Senate Panel Approves $200 Million for FDA to Crack Down on Illegal E-Cigarettes and Nicotine Pouches, and Urges Faster Product Reviews
U.S. Senate Panel Approves $200 Million for FDA to Crack Down on Illegal E-Cigarettes and Nicotine Pouches, and Urges Faster Product Reviews
The U.S. Senate Appropriations Committee approved $200 million for the FDA to crack down on illegal e-cigarettes and nicotine pouches and urged faster premarket product reviews. The bill now moves to the full Senate and still requires further approval and presidential signing.
Jul.15
Russian MMA Fighter Sparks Outrage After Forcing Chimpanzee to Vape; Animal’s Health Deteriorates, Surgery May Be Needed
Russian MMA Fighter Sparks Outrage After Forcing Chimpanzee to Vape; Animal’s Health Deteriorates, Surgery May Be Needed
Russian MMA fighter Anastasia Luchkina has faced global backlash after filming a video of a chimpanzee vaping at a wildlife park in Crimea. According to park officials, the chimpanzee is experiencing a health crisis after ingesting vape liquid and may require surgery.
Jul.04 by 2FIRSTS.ai
Product|Two New Disposable Vapes with Up to 100,000 Puffs Hit the U.S. Market
Product|Two New Disposable Vapes with Up to 100,000 Puffs Hit the U.S. Market
Horizon Tech 100K and Olit Hookalit Pro 60K recently launched in the U.S. market, offering 100,000 and 60,000 puffs respectively. Both devices deliver over 2,000 puffs per milliliter of e-liquid and are equipped with high-capacity 1500mAh batteries.
Jun.04 by 2FIRSTS.ai
Indian Tobacco Control Expert Contributes to 2Firsts: Understanding India’s Smokeless Landscape
Indian Tobacco Control Expert Contributes to 2Firsts: Understanding India’s Smokeless Landscape
On the occasion of World No Tobacco Day 2025, Indian tobacco control expert Dr. Kiran Melkote contributed an article to 2Firsts, providing a comprehensive overview of the current landscape of smokeless tobacco products in India, the associated risks, and his recommendations for the future.
Jun.03
Ireland Health Survey: Youth Vaping on the Rise, 24% Usage Rate Among 18–34 Age Group
Ireland Health Survey: Youth Vaping on the Rise, 24% Usage Rate Among 18–34 Age Group
Ireland’s Central Statistics Office reports that 23.6% of people aged 18–34 use e-cigarettes, while traditional smoking is most prevalent among those aged 45–54 (13.3%). The survey also found only 50.8% of 18–24-year-olds rated their mental health as “very good,” with cannabis use reaching 22%, highlighting significant health risks among younger demographics.
Jul.14 by 2FIRSTS.ai